Karuna Therapeutics Inc reports results for the quarter ended in September - Earnings Summary

Karuna Therapeutics

02/11/2023 13:32

* Karuna Therapeutics Inc  KRTX.OQ  reported a quarterly
adjusted
loss of $3.16​​ per share for the quarter ended in September,
lower than the same quarter last year, when the company reported
EPS of $-2.38.  The mean expectation of nineteen analysts for
the quarter was for a loss of $2.74 per share. Wall Street
expected results to range from $-3.33 to $-2.00 per share.
    * Reported revenue was zero​; analysts expected $1.26
million. 
    * Karuna Therapeutics Inc's reported EPS for the quarter was
a
loss of $3.16​.
    * The company reported a quarterly loss of $119.12 million.
    * Karuna Therapeutics Inc shares had risen by 2.4% this
quarter and lost 11.9% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 1.4%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 18 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 
    * Wall Street's median 12-month price target for Karuna
Therapeutics Inc is $270.00 

This summary was machine generated from LSEG data November 2 at
01:31 p.m. UTC. ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2023      -2.74          -3.16          Missed
 Jun. 30 2023      -2.78          -2.75          Beat
 Mar. 31 2023      -2.76          -2.80          Missed
 Dec. 31 2022      -2.25          -2.22          Beat